Bernt Endrerud

D'Liver AS is a contract research organization that provides laboratory services, products, and consulting within biotechnology and drug development. It performs in depth liver uptake, distribution, and metabolism assays. The firm also offers in vivo liver uptake studies of xenobiotics with special emphasis on biopharmaceuticals, pharmacokinetics, and biodistribution assays. The company was founded by Bård Helge Smedsrød, Kjetil H. Elvevold, Marsil Andelov Al-Mahamid, Mari Nilsen, and Tage Skotvold on January 7, 2011 and is headquartered in Tromsø, Norway.

D'Liver AS is a contract research organization that provides laboratory services, products, and consulting within biotechnology and drug development. It performs in depth liver uptake, distribution, and metabolism assays. The firm also offers in vivo liver uptake studies of xenobiotics with special emphasis on biopharmaceuticals, pharmacokinetics, and biodistribution assays. The company was founded by Bård Helge Smedsrød, Kjetil H. Elvevold, Marsil Andelov Al-Mahamid, Mari Nilsen, and Tage Skotvold on January 7, 2011 and is headquartered in Tromsø, Norway.

Hopen Invest AS invests in other companies. It also owns and manages real estate. The company was founded on July 3, 2008 and is headquartered in Tromsø, Norway.

D'Liver AS is a contract research organization that provides laboratory services, products, and consulting within biotechnology and drug development. It performs in depth liver uptake, distribution, and metabolism assays. The firm also offers in vivo liver uptake studies of xenobiotics with special emphasis on biopharmaceuticals, pharmacokinetics, and biodistribution assays. The company was founded by Bård Helge Smedsrød, Kjetil H. Elvevold, Marsil Andelov Al-Mahamid, Mari Nilsen, and Tage Skotvold on January 7, 2011 and is headquartered in Tromsø, Norway.

D'Liver AS is a contract research organization that provides laboratory services, products, and consulting within biotechnology and drug development. It performs in depth liver uptake, distribution, and metabolism assays. The firm also offers in vivo liver uptake studies of xenobiotics with special emphasis on biopharmaceuticals, pharmacokinetics, and biodistribution assays. The company was founded by Bård Helge Smedsrød, Kjetil H. Elvevold, Marsil Andelov Al-Mahamid, Mari Nilsen, and Tage Skotvold on January 7, 2011 and is headquartered in Tromsø, Norway.